dr. burris on the utility of sacituzumab govitecan in metastatic tnbc
Published 3 years ago • 184 plays • Length 1:00Download video MP4
Download video MP3
Similar videos
-
0:59
dr. burris on treatment considerations in tnbc
-
2:06
dr. burris on recent advances in tnbc
-
4:17
treatment options in metastatic tnbc
-
1:24
dr. burris on the potential of parp inhibitors in tnbc
-
1:36
real-word efficacy of sacituzumab govitecan in metastatic triple-negative breast cancer
-
5:16
study of sacituzumab govitecan for triple-negative breast cancer
-
0:58
dr. burris on investigational approaches in tnbc
-
0:52
dr. burris on predictive biomarkers for chemoimmunotherapy in tnbc
-
2:40
dr. bardia on sacituzumab govitecan in triple-negative breast cancer
-
1:47
dr. bardia on sacituzumab govitecan in tnbc
-
0:46
dr. burris on the incorporation of biosimilars in oncology
-
4:07
px triplenegbreast seg01
-
1:09
dr. burris discusses promise of t-dm1 in her2 breast cancer
-
0:34
copy of dr. burris discusses promise of t-dm1 in her2 breast cancer
-
0:35
dr. brufsky discusses bevacizumab benefits in tnbc
-
1:04
dr. burris discusses pathological cr as an endpoint
-
1:18
dr. tagawa on next steps with sacituzumab govitecan in advanced urothelial carcinoma
-
2:00
dr. hurvitz on treatment hypotheses for tnbc
-
1:55
an expert explains the three major treatment modalities in triple negative breast cancer